BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30043319)

  • 21. TCF3-activated LINC00152 exerts oncogenic role in osteosarcoma through regulating miR-1182/CDK14 axis.
    Zheng L; Hu N; Zhou X
    Pathol Res Pract; 2019 Feb; 215(2):373-380. PubMed ID: 30600185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
    Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
    Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.
    Kim EH; Jo Y; Sai S; Park MJ; Kim JY; Kim JS; Lee YJ; Cho JM; Kwak SY; Baek JH; Jeong YK; Song JY; Yoon M; Hwang SG
    Oncogene; 2019 Sep; 38(39):6630-6646. PubMed ID: 31375748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA
    Ji J; Xu R; Ding K; Bao G; Zhang X; Huang B; Wang X; Martinez A; Wang X; Li G; Miletic H; Thorsen F; Bjerkvig R; Xiang L; Han B; Chen A; Li X; Wang J
    Clin Cancer Res; 2019 Nov; 25(22):6868-6881. PubMed ID: 31492748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment.
    Nandhu MS; Kwiatkowska A; Bhaskaran V; Hayes J; Hu B; Viapiano MS
    Oncogene; 2017 Aug; 36(34):4875-4886. PubMed ID: 28414309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a long noncoding RNA signature to predict outcomes of glioblastoma.
    Li D; Lu J; Li H; Qi S; Yu L
    Mol Med Rep; 2019 Jun; 19(6):5406-5416. PubMed ID: 31059035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway.
    Zhou J; Zhi X; Wang L; Wang W; Li Z; Tang J; Wang J; Zhang Q; Xu Z
    J Exp Clin Cancer Res; 2015 Nov; 34():135. PubMed ID: 26538117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DGCR5 suppresses the EMT of pediatric primary glioblastoma multiforme cell and serves as a prognostic biomarker.
    Yang F; Huang YL
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10024-10034. PubMed ID: 31799672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.
    Rinkenbaugh AL; Cogswell PC; Calamini B; Dunn DE; Persson AI; Weiss WA; Lo DC; Baldwin AS
    Oncotarget; 2016 Oct; 7(43):69173-69187. PubMed ID: 27732951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Noncoding RNA LINC00152 Facilitates the Leukemogenesis of Acute Myeloid Leukemia by Promoting CDK9 Through miR-193a.
    Zhang X; Tao W
    DNA Cell Biol; 2019 Mar; 38(3):236-242. PubMed ID: 30707636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA UCA1/miR-182/PFKFB2 axis modulates glioblastoma-associated stromal cells-mediated glycolysis and invasion of glioma cells.
    He Z; You C; Zhao D
    Biochem Biophys Res Commun; 2018 Jun; 500(3):569-576. PubMed ID: 29655792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
    Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
    Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
    Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma.
    Voce DJ; Bernal GM; Wu L; Crawley CD; Zhang W; Mansour NM; Cahill KE; Szymura SJ; Uppal A; Raleigh DR; Spretz R; Nunez L; Larsen G; Khodarev NN; Weichselbaum RR; Yamini B
    Cancer Res; 2019 May; 79(10):2536-2548. PubMed ID: 30940658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long noncoding RNA FTX promotes a malignant phenotype in bone marrow mesenchymal stem cells via the miR-186/c-Met axis.
    Liu L; Li X; Shi Y; Chen H
    Biomed Pharmacother; 2020 Nov; 131():110666. PubMed ID: 32853911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of downregulated lncRNA NBAT1 on the biological behavior of glioblastoma cells.
    Liu J; Wang WM; Zhang XL; Du QH; Li HG; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2715-2722. PubMed ID: 29771423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.